Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of an effective and safe bolus dose and lockout time for patient-controlled sedation (PCS) using dexmedetomidine in dental treatments: a randomized clinical trial

  • Seung-Hyun Rhee (Department of Dental Anesthesiology, School of Dentistry, Seoul National University) ;
  • Young-Seok Kweon (Department of Brain and Cognitive Engineering, Korea University) ;
  • Dong-Ok Won (Department of Artificial Intelligence Convergence, Hallym University) ;
  • Seong-Whan Lee (Department of Artificial Intelligence, Korea University) ;
  • Kwang-Suk Seo (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
  • Received : 2023.12.31
  • Accepted : 2024.01.25
  • Published : 2024.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study investigated a safe and effective bolus dose and lockout time for patient-controlled sedation (PCS) with dexmedetomidine for dental treatments. The depth of sedation, vital signs, and patient satisfaction were investigated to demonstrate safety. Methods: Thirty patients requiring dental scaling were enrolled and randomly divided into three groups based on bolus doses and lockout times: group 1 (low dose group, bolus dose 0.05 ㎍/kg, 1-minute lockout time), group 2 (middle dose group, 0.1 ㎍/kg, 1-minute), and group 3 (high dose group, 0.2 ㎍/kg, 3-minute) (n = 10 each). ECG, pulse, oxygen saturation, blood pressure, end-tidal CO2, respiratory rate, and bispectral index scores (BIS) were measured and recorded. The study was conducted in two stages: the first involved sedation without dental treatment and the second included sedation with dental scaling. Patients were instructed to press the drug demand button every 10 s, and the process of falling asleep and waking up was repeated 1-5 times. In the second stage, during dental scaling, patients were instructed to press the drug demand button. Loss of responsiveness (LOR) was defined as failure to respond to auditory stimuli six times, determining sleep onset. Patient and dentist satisfaction were assessed before and after experimentation. Results: Thirty patients (22 males) participated in the study. Scaling was performed in 29 patients after excluding one who experienced dizziness during the first stage. The average number of drug administrations until first LOR was significantly lower in group 3 (2.8 times) than groups 1 and 2 (8.0 and 6.5 times, respectively). The time taken to reach the LOR showed no difference between groups. During the second stage, the average time required to reach the LOR during scaling was 583.4 seconds. The effect site concentrations (Ce) was significantly lower in group 1 than groups 2 and 3. In the participant survey on PCS, 8/10 in group 3 reported partial memory loss, whereas 17/20 in groups 1 and 2 recalled the procedure fully or partially. Conclusion: PCS with dexmedetomidine can provide a rapid onset of sedation, safe vital sign management, and minimal side effects, thus facilitating smooth dental sedation.

Keywords

Acknowledgement

This study was supported by grant no 04-2018-0099 from the Seoul National University Dental Hospital Research Fund.

References

  1. Locker D, Shapiro D, Liddell A. Negative dental experiences and their relationship to dental anxiety. Community dental health 1996; 13: 86-92. 
  2. Chanpong B, Haas DA, Locker D. Need and demand for sedation or general anesthesia in dentistry: a national survey of the canadian population. Anesth Prog 2005; 52: 3-11.  https://doi.org/10.2344/0003-3006(2005)52[3:NADFSO]2.0.CO;2
  3. Milgrom P, Newton JT, Boyle C, Heaton LJ, Donaldson N. The effects of dental anxiety and irregular attendance on referral for dental treatment under sedation within the national health service in london. Community Dent Oral Epidemiol 2010; 38: 453-9.  https://doi.org/10.1111/j.1600-0528.2010.00552.x
  4. Sanborn PA, Michna E, Zurakowski D, Burrows PE, Fontaine PJ, Connor L, et al. Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations. Radiology 2005; 237: 288-94.  https://doi.org/10.1148/radiol.2371041415
  5. Dionne RA, Yagiela JA, Moore PA, Gonty A, Zuniga J, Beirne OR. Comparing efficacy and safety of four intravenous sedation regimens in dental outpatients. J Am Dent Assoc 2001; 132: 740-51.  https://doi.org/10.14219/jada.archive.2001.0271
  6. Green SM, Mason KP, Krauss BS. Pulmonary aspiration during procedural sedation: a comprehensive systematic review. Br J Anaesth 2017; 118: 344-54.  https://doi.org/10.1093/bja/aex004
  7. Manley MC, Skelly AM, Hamilton AG. Dental treatment for people with challenging behaviour: General anaesthesia or sedation? Br Dent J 2000; 188: 358-60.  https://doi.org/10.1038/sj.bdj.4800480a
  8. Rudkin GE, Osborne GA, Curtis NJ. Intra-operative patient-controlled sedation. Anaesthesia 1991; 46: 90-2.  https://doi.org/10.1111/j.1365-2044.1991.tb09345.x
  9. Thorpe SJ, Balakrishnan VR, Cook LB. The safety of patient-controlled sedation. Anaesthesia 1997; 52: 1144-50.  https://doi.org/10.1111/j.1365-2044.1997.247-az0395.x
  10. Seo KS. Patient-controlled sedation for dental treatment. J Korean Dent Soc Anesthesiol 2013; 13: 81-7.  https://doi.org/10.17245/jkdsa.2013.13.3.81
  11. Rudkin GE, Osborne GA, Finn BP, Jarvis DA, Vickers D. Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with patient-controlled midazolam. Anaesthesia 1992; 47: 376-81.  https://doi.org/10.1111/j.1365-2044.1992.tb02216.x
  12. Garip H, Gurkan Y, Toker K, Goker K. A comparison of midazolam and midazolam with remifentanil for patient-controlled sedation during operations on third molars. Br J Oral Maxillofac Surg 2007; 45: 212-6.  https://doi.org/10.1016/j.bjoms.2006.06.002
  13. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-8; discussion 269-70.  https://doi.org/10.2165/00003495-200059020-00014
  14. Coughlan MG, Lee JG, Bosnjak ZJ, Schmeling WT, Kampine JP, Warltier DC. Direct coronary and cerebral vascular responses to dexmedetomidinesignificance of endogenous nitric oxide synthesis. Anesthesiology 1992; 77: 998-1006.  https://doi.org/10.1097/00000542-199211000-00024
  15. Bajwa SJ, Kaur J, Singh A, Parmar S, Singh G, Kulshrestha A, et al. Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine. Indian J Anaesth 2012; 56: 123-8.  https://doi.org/10.4103/0019-5049.96303
  16. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.  https://doi.org/10.1097/00000542-200008000-00016
  17. Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101: 1066-76.  https://doi.org/10.1097/00000542-200411000-00005
  18. Rodrigo C. Patient-controlled sedation. Anesth Prog 1998; 45: 117-26. 
  19. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole. J Clin Anesth 1993; 5: 194-203.  https://doi.org/10.1016/0952-8180(93)90014-6
  20. Mason KP, Zgleszewski SE, Dearden JL, Dumont RS, Pirich MA, Stark CD, et al. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006; 103: 57-62.  https://doi.org/10.1213/01.ane.0000216293.16613.15
  21. Rodrigo MR, Fung SC. Comparison of two techniques of patient-controlled sedation with midazolam. Br J Oral Maxillofac Surg 1999; 37: 472-6.  https://doi.org/10.1054/bjom.1999.0118
  22. Chi SI, Kim HJ, Seo KS. Dexmedetomidine intravenous sedation using a patient-controlled sedation infusion pump: a case report. J Dent Anesth Pain Med 2016; 16: 55-9.  https://doi.org/10.17245/jdapm.2016.16.1.55
  23. Ahmed SS, Unland T, Slaven JE, Nitu ME. High dose dexmedetomidine: effective as a sole agent sedation for children undergoing mri. Int J Pediatr 2015; 2015: 397372. 
  24. Yeom SK, Won DO, Chi SI, Seo KS, Kim HJ, Muller KR, et al. Spatio-temporal dynamics of multimodal eeg-fnirs signals in the loss and recovery of consciousness under sedation using midazolam and propofol. PLoS One 2017; 12: e0187743. 
  25. Hannivoort LN, Eleveld DJ, Proost JH, Reyntjens KM, Absalom AR, Vereecke HE, et al. Development of an optimized pharmacokinetic model of dexmedetomidine using target-controlled infusion in healthy volunteers. Anesthesiology 2015; 123: 357-67.  https://doi.org/10.1097/ALN.0000000000000740
  26. Colin PJ, Hannivoort LN, Eleveld DJ, Reyntjens KMEM, Absalom AR, Vereecke HEM, et al. Dexmedetomidine pharmacokinetic-pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation. Br J Anaesth 2017; 119: 200-10.  https://doi.org/10.1093/bja/aex085
  27. Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth 2015; 115: 171-82.  https://doi.org/10.1093/bja/aev226
  28. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 2017; 56: 893-913.  https://doi.org/10.1007/s40262-017-0507-7
  29. Dawes J, Myers D, Gorges M, Zhou G, Ansermino JM, Montgomery CJ. Identifying a rapid bolus dose of dexmedetomidine (ED 50) with acceptable hemodynamic outcomes in children. Paediatr Anaesth 2014; 24: 1260-7.  https://doi.org/10.1111/pan.12468
  30. Siddappa R, Riggins J, Kariyanna S, Calkins P, Rotta AT. High-dose dexmedetomidine sedation for pediatric MRI. Paediatr Anaesth 2011; 21: 153-8.  https://doi.org/10.1111/j.1460-9592.2010.03502.x
  31. Nilsson A, Steinvall I, Bak Z, Sjoberg F. Patient controlled sedation using a standard protocol for dressing changes in burns: patients' preference, procedural details and a preliminary safety evaluation. Burns 2008; 34: 929-34.  https://doi.org/10.1016/j.burns.2008.04.002
  32. Tokumine J, Iha H, Okuda Y, Shimabukuro T, Shimabukuro T, Ishigaki K, et al. Appropriate method of administration of propofol, fentanyl, and ketamine for patient-controlled sedation and analgesia during extracorporeal shock-wave lithotripsy. J Anesth 2000; 14: 68-72.  https://doi.org/10.1007/s005400050069
  33. Barends CR, Absalom A, van Minnen B, Vissink A, Visser A. Dexmedetomidine versus midazolam in procedural sedation. a systematic review of efficacy and safety. PLoS One 2017; 12: e0169525. 
  34. Clarkson K, Power CK, O'Connell F, Pathmakanthan S, Burke CM. A comparative evaluation of propofol and midazolam as sedative agents in fiberoptic bronchoscopy. Chest 1993; 104: 1029-31.  https://doi.org/10.1378/chest.104.4.1029
  35. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs 1984; 28: 519-43.  https://doi.org/10.2165/00003495-198428060-00002
  36. Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. J Clin Diagn Res 2014; 8: GC04-7.  https://doi.org/10.7860/JCDR/2014/8797.4817
  37. Colin PJ, Hannivoort LN, Eleveld DJ, Reyntjens KMEM, Absalom AR, Vereecke HEM, et al. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile. Br J Anaesth 2017; 119: 211-20.  https://doi.org/10.1093/bja/aex086
  38. Figueroa XF, Poblete MI, Boric MP, Mendizabal VE, Adler-Graschinsky E, Huidobro-Toro JP. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial α2-adrenoceptor activation. Br J Pharmacol 2001; 134: 957-68.  https://doi.org/10.1038/sj.bjp.0704320
  39. Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 2003; 99: 65-70.  https://doi.org/10.1097/00000542-200307000-00014
  40. Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG. A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia 2007; 62: 1132-8.  https://doi.org/10.1111/j.1365-2044.2007.05230.x
  41. Levanen J, Makela ML, Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology 1995; 82: 1117-25. https://doi.org/10.1097/00000542-199505000-00005